DCGO

DocGo Inc

Add to Watchlist

Advanced Chart

1.450

-0.04(-2.685%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

1.495

Open

1.495

VWAP

Vol

44.51K

Mkt Cap

147.67M

Low

1.445

Amount

EV/EBITDA(TTM)

7.55

Total Shares

101.57M

107.76M

EV/OCF(TTM)

1.19

P/S(TTM)

0.30

DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

77.58M

-52.97%

68.37M

-50.7%

72.49M

-40.01%

Estimates Revision

The market is revising Downward the revenue expectations for DocGo Inc. (DCGO) for FY2025, with the revenue forecasts being adjusted by -20.08% over the past three months. During the same period, the stock price has changed by -36.40%.

Revenue Estimates for FY2025

Revise Downward

-20.08%

In Past 3 Month

Stock Price

Go Down

-36.40%

In Past 3 Month

5 Analyst Rating

Wall Street analysts forecast DCGO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DCGO is 3.11 USD with a low forecast of 1.45 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

2 Hold

0 Sell

Moderate Buy

Current: 1.450

Low

1.45

Averages

3.11

High

4.00

Current: 1.450

Low

1.45

Averages

3.11

High

4.00

Canaccord

Buy

Hold

downgrade

2025-05-12

Reason

Canaccord

Price Target

2025-05-12

downgrade

Buy

Hold

Reason

Northland

Outperform

downgrade

$6 -> $4

2025-05-12

Reason

Northland

Price Target

$6 -> $4

2025-05-12

downgrade

Outperform

Reason

BTIG

Buy -> Neutral

downgrade

2025-05-09

Reason

BTIG

Price Target

2025-05-09

downgrade

Buy -> Neutral

Reason

Stifel

David Grossman

Buy

downgrade

2025-05-09

Reason

Stifel

David Grossman

Price Target

2025-05-09

downgrade

Buy

Reason

Canaccord

Richard Close

Buy

Hold

downgrade

2025-05-09

Reason

Canaccord

Richard Close

Price Target

2025-05-09

downgrade

Buy

Hold

Reason

Canaccord analyst Richard Close downgraded DocGo to Hold from Buy with a price target of $1.45, down from $5.

Canaccord

Richard Close

Buy

Hold

downgrade

2025-05-09

Reason

Canaccord

Richard Close

Price Target

2025-05-09

downgrade

Buy

Hold

Reason

Canaccord analyst Richard Close downgraded DocGo to Hold from Buy with a price target of $1.45, down from $5.

See All Ratings

Valuation Metrics

The current forward P/E ratio for DocGo Inc (DCGO.O) is -4.27, compared to its 5-year average forward P/E of 37.24. For a more detailed relative valuation and DCF analysis to assess DocGo Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

37.24

Current PE

-4.27

Overvalued PE

75.99

Undervalued PE

-1.50

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

10.56

Current EV/EBITDA

-5.69

Overvalued EV/EBITDA

17.58

Undervalued EV/EBITDA

3.53

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.09

Current PS

0.48

Overvalued PS

1.71

Undervalued PS

0.47

Financials

Annual

Quarterly

FY2025Q1

YoY :

-50.01%

96.03M

Total Revenue

FY2025Q1

YoY :

-188.17%

-14.00M

Operating Profit

FY2025Q1

YoY :

-204.49%

-11.08M

Net Income after Tax

FY2025Q1

YoY :

-190.00%

-0.09

EPS - Diluted

FY2025Q1

YoY :

-160.45%

7.47M

Free Cash Flow

FY2025Q1

YoY :

-14.12%

28.21

Gross Profit Margin - %

FY2025Q1

YoY :

-289.25%

16.20

FCF Margin - %

FY2025Q1

YoY :

-309.06%

-11.54

Net Margin - %

FY2025Q1

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

174.1K

USD

0-12

Months

0.0

USD

Bought

0-3

116.7K

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

1.9M

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

174.1K

USD

0-12

Months

0.0

USD

Bought

0-3

116.7K

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

DCGO News & Events

Events Timeline

2025-05-08 (ET)

2025-05-08

16:10:29

DocGo reports Q1 EPS (9c) consensus 3c

2025-05-08

16:09:35

DocGo sees FY25 revenue $300M-$330M, consensus $410.48M

2025-02-27 (ET)

2025-02-27

16:22:23

DocGo sees FY25 revenue $410M-$450M, consensus $418.63M

News

4.5

07-28NASDAQ.COM

Monday Sector Leaders: Diagnostics, Oil & Gas Exploration & Production Stocks

7.0

07-17PRnewswire

DocGo Inc. (NASDAQ: DCGO) Investor Alert: Schubert Jonckheer Investigates Possible False Statements and Insider Trading

6.0

07-01Newsfilter

DocGo to Provide Medical Transportation Services to Albany Stratton VA Medical Center

People Also Watch

Community Health Systems Inc

Hain Celestial Group Inc

Organogenesis Holdings Inc

China Yuchai International Ltd

Methode Electronics Inc

Astria Therapeutics Inc

Theravance Biopharma Inc

11.040

USD

-0.18%

FAQ

What is DocGo Inc (DCGO) stock price today?

The current price of DCGO is 1.45 USD — it has decreased -2.68 % in the last trading day.

DCGO

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

DCGO News & Events

Events Timeline

News

People Also Watch

FAQ

What is DocGo Inc (DCGO) stock price today?

What is DocGo Inc (DCGO)'s business?

What is the price predicton of DCGO Stock?

What is DocGo Inc (DCGO)'s revenue for the last quarter?

What is DocGo Inc (DCGO)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for DocGo Inc (DCGO)'s fundamentals?

How many employees does DocGo Inc (DCGO). have?

What is DocGo Inc (DCGO) market cap?